CUV clinuvel pharmaceuticals limited

Ann: Further Research Coverage Initiated on CLINUVEL, page-4

  1. 578 Posts.
    lightbulb Created with Sketch. 84
    I think the age reported the price target to be 30. I'm not sure on the basis of the target though (6m, 12m, etc.).

    Remember that Wolgen said the US cash payment cycle was a little longer than Europe at 60-120 days. If that means 90 days on and average, then the upcoming 4C cash flow report should essentially capture cash associated with revenues (sales) from the previous quarter (Apr to June) I. E. Approximately A$1m as reported in the FY results.

    There is nothing to stop them telling us what the unaudited July - Sep revenues have been, and this would be a very interesting number to see, but this is not what is required in a 4C statement. The first 4C next year would capture the cash associated with those sales.
    The upcoming strategy presentation should be interesting, and that combined with strong revenue growth from the US over the medium term could be powerful.
    Last edited by Frogster: 16/10/20
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$10.35
Change
0.360(3.60%)
Mkt cap ! $518.7M
Open High Low Value Volume
$10.01 $10.38 $9.96 $1.031M 100.9K

Buyers (Bids)

No. Vol. Price($)
1 99 $10.22
 

Sellers (Offers)

Price($) Vol. No.
$10.35 1995 1
View Market Depth
Last trade - 16.10pm 03/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.